Impact of excessive daytime sleepiness on the progression of freezing of gait in de novo Parkinson’s disease: a cohort study
EDS is a potential prognosis factor for the progression of FOG in patients with PD.
Authors
- Tinghua Zheng
- Yanjie Guo
- Jingyang Song
- H. Xing (ORCID: https://orcid.org/0000-0002-2096-7249)
- Min Chen (ORCID: https://orcid.org/0000-0003-1856-6910)
- Xuewei Zhang
- Maoyun Zhao
- Feng-Tao Liu
Institutions
- Henan Institute of Technology (CN)
- Huashan Hospital (CN)
- Henan Medical University (CN)
Publication Details
- Journal
- Neurological Sciences
- Published
- 2024-09-26
- DOI
- https://doi.org/10.1007/s10072-024-07738-8
- Citations
- 1
- Primary Topic
- Parkinson's Disease Mechanisms and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.37
Funders
- Bristol-Myers Squibb
- Eli Lilly and Company
- Pfizer
- Sanofi
- Biogen
- Teva Pharmaceutical Industries
- Celgene
- Neurocrine Biosciences
- Verily Life Sciences
- Voyager Therapeutics
- Natural Science Foundation of Henan Province
- Servier
- H. Lundbeck A/S
- Sun Pharma
- Genentech
- Allergan
- Avid Radiopharmaceuticals